Acura Pharmaceuticals reported -300000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acelrx Pharmaceuticals ACRX:US $ -13573000 4.58M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
Johnson & Johnson JNJ:US $ 5840M 22M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Pfizer PFE:US $ 12102M 2229M
Rigel Pharmaceuticals RIGL:US $ -12.96M 13.3M
Shionogi 4507:JP Y 12421M 37469M
Sun Pharmaceuticals SUNP:IN IR 21507.2M 44635.9M
Teva Pharmaceutical TEVA:IT -949000000 236M
Xeris Pharmaceuticals Inc XERS:US $ -18916000 10.16M